nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—CAD—Pyrimidine metabolism—NT5C3A—bone cancer	0.0413	0.0859	CbGpPWpGaD
L-Glutamine—CTPS1—Nucleotide metabolism—NT5C3A—bone cancer	0.028	0.0582	CbGpPWpGaD
L-Glutamine—GMPS—Nucleotide metabolism—NT5C3A—bone cancer	0.0249	0.0519	CbGpPWpGaD
L-Glutamine—PFAS—Nucleotide metabolism—NT5C3A—bone cancer	0.0249	0.0519	CbGpPWpGaD
L-Glutamine—GFPT2—Asparagine N-linked glycosylation—MOGS—bone cancer	0.0201	0.0418	CbGpPWpGaD
L-Glutamine—NADSYN1—Nicotinate metabolism—PTGS2—bone cancer	0.0167	0.0347	CbGpPWpGaD
L-Glutamine—CAD—Nucleotide metabolism—NT5C3A—bone cancer	0.0161	0.0334	CbGpPWpGaD
L-Glutamine—PPAT—Nucleotide metabolism—NT5C3A—bone cancer	0.0147	0.0306	CbGpPWpGaD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—GNA11—bone cancer	0.0139	0.0288	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—BMI1—bone cancer	0.0124	0.0257	CbGpPWpGaD
L-Glutamine—PPAT—Fluoropyrimidine Activity—DHFR—bone cancer	0.0119	0.0247	CbGpPWpGaD
L-Glutamine—ASNS—PERK regulates gene expression—EIF2S1—bone cancer	0.0113	0.0235	CbGpPWpGaD
L-Glutamine—TGM5—spinal cord—bone cancer	0.011	0.0435	CbGeAlD
L-Glutamine—GFPT2—Post-translational protein modification—MOGS—bone cancer	0.0104	0.0216	CbGpPWpGaD
L-Glutamine—GLS—connective tissue—bone cancer	0.00993	0.0393	CbGeAlD
L-Glutamine—TGM2—connective tissue—bone cancer	0.00982	0.0389	CbGeAlD
L-Glutamine—GMPS—connective tissue—bone cancer	0.00925	0.0366	CbGeAlD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.00849	0.0177	CbGpPWpGaD
L-Glutamine—F13A1—connective tissue—bone cancer	0.00815	0.0322	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—SPARC—bone cancer	0.00769	0.016	CbGpPWpGaD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00733	0.0152	CbGpPWpGaD
L-Glutamine—CCBL1—tendon—bone cancer	0.00724	0.0287	CbGeAlD
L-Glutamine—GATB—tendon—bone cancer	0.00724	0.0287	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—PLAU—bone cancer	0.00722	0.015	CbGpPWpGaD
L-Glutamine—CCBL1—spinal cord—bone cancer	0.00699	0.0277	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—EIF2S1—bone cancer	0.00692	0.0144	CbGpPWpGaD
L-Glutamine—GLS—tendon—bone cancer	0.00682	0.027	CbGeAlD
L-Glutamine—GLS—bone marrow—bone cancer	0.00661	0.0262	CbGeAlD
L-Glutamine—CTPS1—tendon—bone cancer	0.00636	0.0252	CbGeAlD
L-Glutamine—GMPS—tendon—bone cancer	0.00636	0.0252	CbGeAlD
L-Glutamine—PFAS—tendon—bone cancer	0.00624	0.0247	CbGeAlD
L-Glutamine—GFPT2—tendon—bone cancer	0.00624	0.0247	CbGeAlD
L-Glutamine—CTPS1—bone marrow—bone cancer	0.00616	0.0244	CbGeAlD
L-Glutamine—GMPS—bone marrow—bone cancer	0.00616	0.0244	CbGeAlD
L-Glutamine—SLC1A5—connective tissue—bone cancer	0.00613	0.0243	CbGeAlD
L-Glutamine—GMPS—spinal cord—bone cancer	0.00613	0.0243	CbGeAlD
L-Glutamine—PFAS—bone marrow—bone cancer	0.00605	0.0239	CbGeAlD
L-Glutamine—Rectal tenesmus—Epirubicin—bone cancer	0.00602	0.0228	CcSEcCtD
L-Glutamine—GFPT2—spinal cord—bone cancer	0.00602	0.0238	CbGeAlD
L-Glutamine—PFAS—spinal cord—bone cancer	0.00602	0.0238	CbGeAlD
L-Glutamine—F13A1—tendon—bone cancer	0.0056	0.0222	CbGeAlD
L-Glutamine—Rectal tenesmus—Doxorubicin—bone cancer	0.00557	0.0211	CcSEcCtD
L-Glutamine—F13A1—bone marrow—bone cancer	0.00542	0.0215	CbGeAlD
L-Glutamine—F13A1—spinal cord—bone cancer	0.0054	0.0214	CbGeAlD
L-Glutamine—QARS—tendon—bone cancer	0.00532	0.0211	CbGeAlD
L-Glutamine—Infection—Carboplatin—bone cancer	0.00528	0.02	CcSEcCtD
L-Glutamine—Bacterial infection—Methotrexate—bone cancer	0.00519	0.0196	CcSEcCtD
L-Glutamine—QARS—bone marrow—bone cancer	0.00516	0.0204	CbGeAlD
L-Glutamine—QARS—spinal cord—bone cancer	0.00513	0.0203	CbGeAlD
L-Glutamine—QARS—Gene Expression—ZNF77—bone cancer	0.00507	0.0106	CbGpPWpGaD
L-Glutamine—ASNS—Unfolded Protein Response (UPR)—EIF2S1—bone cancer	0.00498	0.0104	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—MOGS—bone cancer	0.00493	0.0103	CbGpPWpGaD
L-Glutamine—CAD—tendon—bone cancer	0.00491	0.0194	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—PLAU—bone cancer	0.00488	0.0102	CbGpPWpGaD
L-Glutamine—Proctalgia—Epirubicin—bone cancer	0.00478	0.0181	CcSEcCtD
L-Glutamine—CAD—bone marrow—bone cancer	0.00476	0.0188	CbGeAlD
L-Glutamine—CAD—spinal cord—bone cancer	0.00473	0.0187	CbGeAlD
L-Glutamine—PPAT—tendon—bone cancer	0.00455	0.018	CbGeAlD
L-Glutamine—Pain—Carboplatin—bone cancer	0.00454	0.0172	CcSEcCtD
L-Glutamine—Proctalgia—Doxorubicin—bone cancer	0.00443	0.0167	CcSEcCtD
L-Glutamine—PPAT—bone marrow—bone cancer	0.00441	0.0175	CbGeAlD
L-Glutamine—PPAT—spinal cord—bone cancer	0.00439	0.0174	CbGeAlD
L-Glutamine—GLUL—connective tissue—bone cancer	0.0043	0.017	CbGeAlD
L-Glutamine—SLC1A5—tendon—bone cancer	0.00422	0.0167	CbGeAlD
L-Glutamine—Body temperature increased—Carboplatin—bone cancer	0.0042	0.0159	CcSEcCtD
L-Glutamine—Anorectal discomfort—Epirubicin—bone cancer	0.0041	0.0155	CcSEcCtD
L-Glutamine—SLC1A5—bone marrow—bone cancer	0.00408	0.0162	CbGeAlD
L-Glutamine—SLC1A5—spinal cord—bone cancer	0.00407	0.0161	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.00394	0.00821	CbGpPWpGaD
L-Glutamine—Gastric ulcer—Epirubicin—bone cancer	0.00386	0.0146	CcSEcCtD
L-Glutamine—Anorectal discomfort—Doxorubicin—bone cancer	0.0038	0.0144	CcSEcCtD
L-Glutamine—SLC7A8—tendon—bone cancer	0.0038	0.015	CbGeAlD
L-Glutamine—Enlargement abdomen—Epirubicin—bone cancer	0.00373	0.0141	CcSEcCtD
L-Glutamine—Nail disorder—Methotrexate—bone cancer	0.0037	0.014	CcSEcCtD
L-Glutamine—ASNS—tendon—bone cancer	0.00362	0.0143	CbGeAlD
L-Glutamine—Gastric ulcer—Doxorubicin—bone cancer	0.00357	0.0135	CcSEcCtD
L-Glutamine—ASNS—bone marrow—bone cancer	0.0035	0.0139	CbGeAlD
L-Glutamine—ASNS—spinal cord—bone cancer	0.00349	0.0138	CbGeAlD
L-Glutamine—Nail disorder—Epirubicin—bone cancer	0.00346	0.0131	CcSEcCtD
L-Glutamine—Enlargement abdomen—Doxorubicin—bone cancer	0.00345	0.013	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.00341	0.0071	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—CDK4—bone cancer	0.0034	0.00707	CbGpPWpGaD
L-Glutamine—Nail disorder—Doxorubicin—bone cancer	0.0032	0.0121	CcSEcCtD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.00319	0.00664	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.00312	0.00649	CbGpPWpGaD
L-Glutamine—Laryngitis—Epirubicin—bone cancer	0.00311	0.0118	CcSEcCtD
L-Glutamine—Fungal infection—Methotrexate—bone cancer	0.0031	0.0117	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—NDUFA12—bone cancer	0.00307	0.00638	CbGpPWpGaD
L-Glutamine—GLUL—tendon—bone cancer	0.00295	0.0117	CbGeAlD
L-Glutamine—Dehydration—Cisplatin—bone cancer	0.00295	0.0111	CcSEcCtD
L-Glutamine—Fungal infection—Epirubicin—bone cancer	0.0029	0.011	CcSEcCtD
L-Glutamine—Laryngitis—Doxorubicin—bone cancer	0.00288	0.0109	CcSEcCtD
L-Glutamine—GLUL—bone marrow—bone cancer	0.00286	0.0113	CbGeAlD
L-Glutamine—GLUL—spinal cord—bone cancer	0.00285	0.0113	CbGeAlD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—IL3—bone cancer	0.00283	0.00589	CbGpPWpGaD
L-Glutamine—Injection site pain—Epirubicin—bone cancer	0.00275	0.0104	CcSEcCtD
L-Glutamine—Rigors—Epirubicin—bone cancer	0.00275	0.0104	CcSEcCtD
L-Glutamine—GMPS—Metabolism—NDUFA12—bone cancer	0.00273	0.00569	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NDUFA12—bone cancer	0.00273	0.00569	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—TUBB4B—bone cancer	0.0027	0.00562	CbGpPWpGaD
L-Glutamine—Fungal infection—Doxorubicin—bone cancer	0.00269	0.0102	CcSEcCtD
L-Glutamine—Pancreatitis—Cisplatin—bone cancer	0.00269	0.0102	CcSEcCtD
L-Glutamine—Sweating increased—Cisplatin—bone cancer	0.00267	0.0101	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—MOGS—bone cancer	0.00266	0.00554	CbGpPWpGaD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—bone cancer	0.00266	0.00553	CbGpPWpGaD
L-Glutamine—Breast pain—Epirubicin—bone cancer	0.00257	0.00972	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—NT5C3A—bone cancer	0.00254	0.00529	CbGpPWpGaD
L-Glutamine—Rigors—Doxorubicin—bone cancer	0.00254	0.00961	CcSEcCtD
L-Glutamine—Injection site pain—Doxorubicin—bone cancer	0.00254	0.00961	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—NDUFA12—bone cancer	0.0025	0.0052	CbGpPWpGaD
L-Glutamine—Viral infection—Epirubicin—bone cancer	0.00248	0.00939	CcSEcCtD
L-Glutamine—QARS—Gene Expression—FUS—bone cancer	0.00248	0.00516	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00242	0.00504	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Cisplatin—bone cancer	0.00239	0.00906	CcSEcCtD
L-Glutamine—Breast pain—Doxorubicin—bone cancer	0.00238	0.00899	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—TUBB2A—bone cancer	0.00233	0.00485	CbGpPWpGaD
L-Glutamine—Viral infection—Doxorubicin—bone cancer	0.0023	0.00869	CcSEcCtD
L-Glutamine—Glutathione—GSTP1—bone cancer	0.00227	1	CrCbGaD
L-Glutamine—PFAS—Metabolism—NT5C3A—bone cancer	0.00227	0.00471	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NT5C3A—bone cancer	0.00227	0.00471	CbGpPWpGaD
L-Glutamine—SLC16A10—tendon—bone cancer	0.00225	0.00891	CbGeAlD
L-Glutamine—Injection site reaction—Epirubicin—bone cancer	0.00223	0.00843	CcSEcCtD
L-Glutamine—GLS—Metabolism—NDUFA12—bone cancer	0.00219	0.00455	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NDUFA12—bone cancer	0.00219	0.00455	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NDUFA12—bone cancer	0.00219	0.00455	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Cisplatin—bone cancer	0.00217	0.00819	CcSEcCtD
L-Glutamine—Urethral disorder—Cisplatin—bone cancer	0.00215	0.00813	CcSEcCtD
L-Glutamine—Candida infection—Epirubicin—bone cancer	0.00214	0.0081	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—MMP9—bone cancer	0.00213	0.00443	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00209	0.00435	CbGpPWpGaD
L-Glutamine—Sepsis—Methotrexate—bone cancer	0.00208	0.00786	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—NT5C3A—bone cancer	0.00207	0.00431	CbGpPWpGaD
L-Glutamine—Injection site reaction—Doxorubicin—bone cancer	0.00206	0.0078	CcSEcCtD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00206	0.00429	CbGpPWpGaD
L-Glutamine—Candida infection—Doxorubicin—bone cancer	0.00198	0.00749	CcSEcCtD
L-Glutamine—Sepsis—Epirubicin—bone cancer	0.00195	0.00736	CcSEcCtD
L-Glutamine—Malnutrition—Cisplatin—bone cancer	0.00191	0.00722	CcSEcCtD
L-Glutamine—Flatulence—Cisplatin—bone cancer	0.00188	0.00711	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—bone cancer	0.00186	0.00704	CcSEcCtD
L-Glutamine—GLS2—Metabolism—NT5C3A—bone cancer	0.00181	0.00377	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NT5C3A—bone cancer	0.00181	0.00377	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NT5C3A—bone cancer	0.00181	0.00377	CbGpPWpGaD
L-Glutamine—Sepsis—Doxorubicin—bone cancer	0.0018	0.00681	CcSEcCtD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00178	0.0037	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—BRAF—bone cancer	0.00177	0.00369	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—BRAF—bone cancer	0.00177	0.00369	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Cisplatin—bone cancer	0.00177	0.0067	CcSEcCtD
L-Glutamine—CAD—Metabolism—NDUFA12—bone cancer	0.00176	0.00367	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—SPARC—bone cancer	0.00176	0.00366	CbGpPWpGaD
L-Glutamine—Hepatic function abnormal—Doxorubicin—bone cancer	0.00172	0.00652	CcSEcCtD
L-Glutamine—Malaise—Cisplatin—bone cancer	0.00172	0.00651	CcSEcCtD
L-Glutamine—QARS—Gene Expression—NR1I2—bone cancer	0.00172	0.00357	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—EIF2S1—bone cancer	0.00163	0.00339	CbGpPWpGaD
L-Glutamine—Myalgia—Cisplatin—bone cancer	0.00163	0.00615	CcSEcCtD
L-Glutamine—PPAT—Metabolism—NDUFA12—bone cancer	0.00161	0.00335	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—GNA11—bone cancer	0.00161	0.00335	CbGpPWpGaD
L-Glutamine—Discomfort—Cisplatin—bone cancer	0.00161	0.00607	CcSEcCtD
L-Glutamine—Oedema—Cisplatin—bone cancer	0.00156	0.00589	CcSEcCtD
L-Glutamine—Infection—Cisplatin—bone cancer	0.00155	0.00585	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00152	0.00317	CbGpPWpGaD
L-Glutamine—Dehydration—Epirubicin—bone cancer	0.00151	0.00573	CcSEcCtD
L-Glutamine—Hyperhidrosis—Cisplatin—bone cancer	0.00151	0.0057	CcSEcCtD
L-Glutamine—GLS2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00149	0.00309	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—MDM2—bone cancer	0.00149	0.00309	CbGpPWpGaD
L-Glutamine—Pancreatitis—Methotrexate—bone cancer	0.00147	0.00557	CcSEcCtD
L-Glutamine—CAD—Metabolism—NT5C3A—bone cancer	0.00146	0.00304	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—TUBB4B—bone cancer	0.00146	0.00304	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—IL3—bone cancer	0.00146	0.00303	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—bone cancer	0.00144	0.00301	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00142	0.00537	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—bone cancer	0.00142	0.00536	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—bone cancer	0.0014	0.0053	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—JUN—bone cancer	0.00138	0.00287	CbGpPWpGaD
L-Glutamine—Pancreatitis—Epirubicin—bone cancer	0.00138	0.00522	CcSEcCtD
L-Glutamine—GLS2—Neuronal System—BRAF—bone cancer	0.00136	0.00283	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—BRAF—bone cancer	0.00136	0.00283	CbGpPWpGaD
L-Glutamine—Depression—Methotrexate—bone cancer	0.00134	0.00506	CcSEcCtD
L-Glutamine—PPAT—Metabolism—NT5C3A—bone cancer	0.00134	0.00278	CbGpPWpGaD
L-Glutamine—Pain—Cisplatin—bone cancer	0.00133	0.00504	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00131	0.00273	CbGpPWpGaD
L-Glutamine—Abdominal distension—Doxorubicin—bone cancer	0.00131	0.00496	CcSEcCtD
L-Glutamine—Feeling abnormal—Cisplatin—bone cancer	0.00128	0.00486	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—bone cancer	0.00128	0.00483	CcSEcCtD
L-Glutamine—QARS—Gene Expression—EIF2S1—bone cancer	0.00127	0.00264	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—TUBB2A—bone cancer	0.00126	0.00262	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NDUFA12—bone cancer	0.00126	0.00261	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NDUFA12—bone cancer	0.00126	0.00261	CbGpPWpGaD
L-Glutamine—Body temperature increased—Cisplatin—bone cancer	0.00123	0.00466	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—bone cancer	0.00123	0.00465	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—bone cancer	0.00119	0.00452	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—bone cancer	0.00119	0.00449	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—bone cancer	0.00118	0.00446	CcSEcCtD
L-Glutamine—Hypersensitivity—Cisplatin—bone cancer	0.00115	0.00434	CcSEcCtD
L-Glutamine—GLS—Neuronal System—MDM2—bone cancer	0.00114	0.00237	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—MDM2—bone cancer	0.00114	0.00237	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00114	0.0043	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—bone cancer	0.00113	0.00427	CcSEcCtD
L-Glutamine—Asthenia—Cisplatin—bone cancer	0.00112	0.00423	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—bone cancer	0.00112	0.00423	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ENO2—bone cancer	0.00111	0.00232	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Epirubicin—bone cancer	0.00111	0.00421	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—bone cancer	0.0011	0.00417	CcSEcCtD
L-Glutamine—QARS—Gene Expression—EZH2—bone cancer	0.0011	0.00229	CbGpPWpGaD
L-Glutamine—Angiopathy—Methotrexate—bone cancer	0.00109	0.00413	CcSEcCtD
L-Glutamine—NADSYN1—Disease—ENO2—bone cancer	0.00108	0.00226	CbGpPWpGaD
L-Glutamine—Chills—Methotrexate—bone cancer	0.00108	0.00408	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—bone cancer	0.00105	0.00399	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—bone cancer	0.00105	0.00396	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—bone cancer	0.00104	0.00395	CcSEcCtD
L-Glutamine—ASNS—Metabolism—NT5C3A—bone cancer	0.00104	0.00216	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NT5C3A—bone cancer	0.00104	0.00216	CbGpPWpGaD
L-Glutamine—Pharyngitis—Doxorubicin—bone cancer	0.00103	0.00391	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—DHFR—bone cancer	0.00103	0.00215	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Doxorubicin—bone cancer	0.00103	0.00389	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—bone cancer	0.00102	0.00386	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—bone cancer	0.00102	0.00386	CcSEcCtD
L-Glutamine—GLUL—Transmission across Chemical Synapses—BRAF—bone cancer	0.00102	0.00212	CbGpPWpGaD
L-Glutamine—Back pain—Methotrexate—bone cancer	0.00101	0.00383	CcSEcCtD
L-Glutamine—Chills—Epirubicin—bone cancer	0.00101	0.00382	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—SPARC—bone cancer	0.00101	0.0021	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—DHFR—bone cancer	0.00101	0.00209	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ENO2—bone cancer	0.000992	0.00206	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ENO2—bone cancer	0.000992	0.00206	CbGpPWpGaD
L-Glutamine—Vomiting—Cisplatin—bone cancer	0.000991	0.00375	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—bone cancer	0.000987	0.00373	CcSEcCtD
L-Glutamine—Rash—Cisplatin—bone cancer	0.000982	0.00372	CcSEcCtD
L-Glutamine—Dermatitis—Cisplatin—bone cancer	0.000982	0.00371	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—bone cancer	0.00098	0.00371	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—bone cancer	0.000972	0.00368	CcSEcCtD
L-Glutamine—Flatulence—Epirubicin—bone cancer	0.000966	0.00365	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GNA11—bone cancer	0.000965	0.00201	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PLAU—bone cancer	0.000957	0.00199	CbGpPWpGaD
L-Glutamine—Back pain—Epirubicin—bone cancer	0.000948	0.00359	CcSEcCtD
L-Glutamine—CCBL1—Disease—ENO2—bone cancer	0.000947	0.00197	CbGpPWpGaD
L-Glutamine—Angiopathy—Doxorubicin—bone cancer	0.000946	0.00358	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—bone cancer	0.000945	0.00357	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—bone cancer	0.000935	0.00354	CcSEcCtD
L-Glutamine—Nausea—Cisplatin—bone cancer	0.000926	0.0035	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—GNA11—bone cancer	0.000924	0.00192	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—DHFR—bone cancer	0.000921	0.00192	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—DHFR—bone cancer	0.000921	0.00192	CbGpPWpGaD
L-Glutamine—Mental disorder—Doxorubicin—bone cancer	0.000913	0.00345	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—bone cancer	0.00091	0.00344	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—ENO2—bone cancer	0.000908	0.00189	CbGpPWpGaD
L-Glutamine—Malnutrition—Doxorubicin—bone cancer	0.000907	0.00343	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—bone cancer	0.000894	0.00338	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—bone cancer	0.000892	0.00337	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—bone cancer	0.000892	0.00337	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—bone cancer	0.000892	0.00337	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—bone cancer	0.000884	0.00334	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000883	0.00184	CbGpPWpGaD
L-Glutamine—Discomfort—Methotrexate—bone cancer	0.000881	0.00333	CcSEcCtD
L-Glutamine—CCBL1—Disease—DHFR—bone cancer	0.000879	0.00183	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—EIF2S1—bone cancer	0.000879	0.00183	CbGpPWpGaD
L-Glutamine—Back pain—Doxorubicin—bone cancer	0.000878	0.00332	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—CYP3A4—bone cancer	0.000875	0.00182	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—GNA11—bone cancer	0.00086	0.00179	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GNA11—bone cancer	0.00086	0.00179	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—MDM2—bone cancer	0.000853	0.00178	CbGpPWpGaD
L-Glutamine—Infection—Methotrexate—bone cancer	0.000849	0.00321	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—DHFR—bone cancer	0.000842	0.00175	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Doxorubicin—bone cancer	0.000842	0.00318	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—IL3—bone cancer	0.000838	0.00174	CbGpPWpGaD
L-Glutamine—Chest pain—Epirubicin—bone cancer	0.000835	0.00316	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—bone cancer	0.000835	0.00316	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—bone cancer	0.000835	0.00316	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—bone cancer	0.000827	0.00313	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—bone cancer	0.000825	0.00312	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—bone cancer	0.000818	0.00309	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—bone cancer	0.000816	0.00309	CcSEcCtD
L-Glutamine—Oedema—Epirubicin—bone cancer	0.0008	0.00303	CcSEcCtD
L-Glutamine—Infection—Epirubicin—bone cancer	0.000795	0.00301	CcSEcCtD
L-Glutamine—GLS—Metabolism—ENO2—bone cancer	0.000793	0.00165	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ENO2—bone cancer	0.000793	0.00165	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ENO2—bone cancer	0.000793	0.00165	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GNA11—bone cancer	0.000787	0.00164	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—BRAF—bone cancer	0.00078	0.00162	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP3A4—bone cancer	0.00078	0.00162	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP3A4—bone cancer	0.00078	0.00162	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000779	0.00295	CcSEcCtD
L-Glutamine—Hyperhidrosis—Epirubicin—bone cancer	0.000774	0.00293	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—bone cancer	0.000773	0.00292	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—bone cancer	0.000772	0.00292	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—bone cancer	0.000772	0.00292	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—bone cancer	0.000772	0.00292	CcSEcCtD
L-Glutamine—Discomfort—Doxorubicin—bone cancer	0.000763	0.00289	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000762	0.00159	CbGpPWpGaD
L-Glutamine—Dry mouth—Doxorubicin—bone cancer	0.000755	0.00286	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GSTP1—bone cancer	0.000749	0.00156	CbGpPWpGaD
L-Glutamine—Oedema—Doxorubicin—bone cancer	0.00074	0.0028	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—bone cancer	0.000737	0.00279	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—DHFR—bone cancer	0.000736	0.00153	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—DHFR—bone cancer	0.000736	0.00153	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—DHFR—bone cancer	0.000736	0.00153	CbGpPWpGaD
L-Glutamine—Infection—Doxorubicin—bone cancer	0.000736	0.00278	CcSEcCtD
L-Glutamine—Pain—Methotrexate—bone cancer	0.000731	0.00276	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000729	0.00276	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TGFBR2—bone cancer	0.000729	0.00152	CbGpPWpGaD
L-Glutamine—Insomnia—Epirubicin—bone cancer	0.000724	0.00274	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—bone cancer	0.000716	0.00271	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CYP3A4—bone cancer	0.000713	0.00148	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Methotrexate—bone cancer	0.000705	0.00266	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—bone cancer	0.000699	0.00264	CcSEcCtD
L-Glutamine—Fatigue—Epirubicin—bone cancer	0.00069	0.00261	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—GNA11—bone cancer	0.000688	0.00143	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GNA11—bone cancer	0.000688	0.00143	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GNA11—bone cancer	0.000688	0.00143	CbGpPWpGaD
L-Glutamine—Constipation—Epirubicin—bone cancer	0.000684	0.00259	CcSEcCtD
L-Glutamine—Pain—Epirubicin—bone cancer	0.000684	0.00259	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—bone cancer	0.000676	0.00256	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—bone cancer	0.000676	0.00256	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000675	0.00255	CcSEcCtD
L-Glutamine—Insomnia—Doxorubicin—bone cancer	0.00067	0.00253	CcSEcCtD
L-Glutamine—PFAS—Metabolism—GSTP1—bone cancer	0.000667	0.00139	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GSTP1—bone cancer	0.000667	0.00139	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—MMP2—bone cancer	0.000666	0.00138	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Epirubicin—bone cancer	0.000659	0.00249	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—bone cancer	0.000654	0.00247	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—MDM2—bone cancer	0.000654	0.00136	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ENO2—bone cancer	0.00064	0.00133	CbGpPWpGaD
L-Glutamine—Fatigue—Doxorubicin—bone cancer	0.000638	0.00241	CcSEcCtD
L-Glutamine—CCBL1—Disease—TGFBR2—bone cancer	0.000637	0.00133	CbGpPWpGaD
L-Glutamine—Constipation—Doxorubicin—bone cancer	0.000633	0.00239	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—bone cancer	0.000633	0.00239	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—bone cancer	0.000633	0.00239	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—bone cancer	0.000633	0.00239	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—bone cancer	0.00063	0.00238	CcSEcCtD
L-Glutamine—GLS—Metabolism—CYP3A4—bone cancer	0.000624	0.0013	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP3A4—bone cancer	0.000624	0.0013	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP3A4—bone cancer	0.000624	0.0013	CbGpPWpGaD
L-Glutamine—Asthenia—Methotrexate—bone cancer	0.000613	0.00232	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—GSTP1—bone cancer	0.00061	0.00127	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Doxorubicin—bone cancer	0.00061	0.00231	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000605	0.00229	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—bone cancer	0.000605	0.00229	CcSEcCtD
L-Glutamine—CAD—Metabolism—DHFR—bone cancer	0.000593	0.00123	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Epirubicin—bone cancer	0.00059	0.00223	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—bone cancer	0.000585	0.00221	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—bone cancer	0.000585	0.00221	CcSEcCtD
L-Glutamine—PPAT—Metabolism—ENO2—bone cancer	0.000585	0.00122	CbGpPWpGaD
L-Glutamine—Asthenia—Epirubicin—bone cancer	0.000574	0.00217	CcSEcCtD
L-Glutamine—Pruritus—Epirubicin—bone cancer	0.000566	0.00214	CcSEcCtD
L-Glutamine—Dizziness—Methotrexate—bone cancer	0.000565	0.00214	CcSEcCtD
L-Glutamine—CAD—Metabolism—GNA11—bone cancer	0.000554	0.00115	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PLAU—bone cancer	0.000549	0.00114	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—bone cancer	0.000545	0.00206	CcSEcCtD
L-Glutamine—Vomiting—Methotrexate—bone cancer	0.000544	0.00206	CcSEcCtD
L-Glutamine—PPAT—Metabolism—DHFR—bone cancer	0.000543	0.00113	CbGpPWpGaD
L-Glutamine—Rash—Methotrexate—bone cancer	0.000539	0.00204	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—bone cancer	0.000539	0.00204	CcSEcCtD
L-Glutamine—Headache—Methotrexate—bone cancer	0.000536	0.00203	CcSEcCtD
L-Glutamine—GLS—Metabolism—GSTP1—bone cancer	0.000533	0.00111	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTP1—bone cancer	0.000533	0.00111	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTP1—bone cancer	0.000533	0.00111	CbGpPWpGaD
L-Glutamine—Asthenia—Doxorubicin—bone cancer	0.000531	0.00201	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—bone cancer	0.000529	0.002	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—bone cancer	0.000524	0.00198	CcSEcCtD
L-Glutamine—Vomiting—Epirubicin—bone cancer	0.000509	0.00192	CcSEcCtD
L-Glutamine—Nausea—Methotrexate—bone cancer	0.000508	0.00192	CcSEcCtD
L-Glutamine—PPAT—Metabolism—GNA11—bone cancer	0.000507	0.00106	CbGpPWpGaD
L-Glutamine—Rash—Epirubicin—bone cancer	0.000505	0.00191	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—bone cancer	0.000504	0.00191	CcSEcCtD
L-Glutamine—CAD—Metabolism—CYP3A4—bone cancer	0.000503	0.00105	CbGpPWpGaD
L-Glutamine—Headache—Epirubicin—bone cancer	0.000501	0.0019	CcSEcCtD
L-Glutamine—NADSYN1—Disease—KIT—bone cancer	0.000497	0.00103	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—bone cancer	0.00049	0.00185	CcSEcCtD
L-Glutamine—Nausea—Epirubicin—bone cancer	0.000475	0.0018	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—bone cancer	0.000471	0.00178	CcSEcCtD
L-Glutamine—NADSYN1—Disease—BRAF—bone cancer	0.000467	0.000972	CbGpPWpGaD
L-Glutamine—Rash—Doxorubicin—bone cancer	0.000467	0.00177	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—bone cancer	0.000466	0.00176	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—bone cancer	0.000464	0.00175	CcSEcCtD
L-Glutamine—PPAT—Metabolism—CYP3A4—bone cancer	0.00046	0.000957	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—bone cancer	0.000456	0.000948	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—bone cancer	0.000456	0.000948	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—bone cancer	0.00044	0.00166	CcSEcCtD
L-Glutamine—CCBL1—Disease—KIT—bone cancer	0.000435	0.000904	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTP1—bone cancer	0.00043	0.000895	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—DHFR—bone cancer	0.000423	0.00088	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—DHFR—bone cancer	0.000423	0.00088	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BRAF—bone cancer	0.000408	0.00085	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GNA11—bone cancer	0.000395	0.000822	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GNA11—bone cancer	0.000395	0.000822	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTP1—bone cancer	0.000393	0.000818	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MDM2—bone cancer	0.000392	0.000815	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—bone cancer	0.000388	0.000807	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—bone cancer	0.000385	0.0008	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—bone cancer	0.000377	0.000785	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP2—bone cancer	0.000359	0.000748	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP3A4—bone cancer	0.000358	0.000745	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP3A4—bone cancer	0.000358	0.000745	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—bone cancer	0.000346	0.000719	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—bone cancer	0.000346	0.000719	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MDM2—bone cancer	0.000342	0.000712	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—bone cancer	0.00033	0.000687	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—bone cancer	0.000316	0.000658	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTP1—bone cancer	0.000306	0.000637	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTP1—bone cancer	0.000306	0.000637	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—bone cancer	0.000276	0.000575	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—bone cancer	0.000276	0.000575	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—bone cancer	0.000276	0.000575	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—bone cancer	0.000268	0.000557	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—bone cancer	0.000234	0.000487	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—bone cancer	0.000223	0.000463	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—bone cancer	0.000221	0.00046	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—bone cancer	0.000204	0.000424	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—bone cancer	0.000159	0.00033	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—bone cancer	0.000159	0.00033	CbGpPWpGaD
